StemCells Inc (STEM.OQ) Analysts | Reuters.com
Edition:
United States

StemCells Inc (STEM.OQ)

STEM.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
30 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
78,622
52-wk High
$7.56
52-wk Low
$0.33

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.66 December 1 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 5 5 5
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 2 0.03 0.04 0.03 0.03
Quarter Ending Dec-16 2 0.03 0.04 0.03 0.03
Year Ending Dec-16 4 0.11 0.20 0.00 0.13
Year Ending Dec-17 2 0.13 0.14 0.12 0.03
Earnings (per share)
Quarter Ending Sep-16 3 -0.66 -0.60 -0.72 -1.00
Quarter Ending Dec-16 3 -0.68 -0.60 -0.72 -0.96
Year Ending Dec-16 4 -3.04 -2.64 -3.96 -3.56
Year Ending Dec-17 2 -1.62 -1.56 -1.68 -2.96

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 0.04 0.02 0.02 43.41
Quarter Ending Dec-15 0.03 0.03 0.01 16.57
Quarter Ending Sep-15 0.03 0.04 0.01 19.35
Quarter Ending Jun-15 0.03 0.03 0.00 2.74
Quarter Ending Mar-15 0.00 0.02 0.02 0.00
Earnings (per share)
Quarter Ending Mar-16 -0.75 -0.98 0.23 -30.67
Quarter Ending Dec-15 -1.06 -0.96 0.10 -9.09
Quarter Ending Sep-15 -1.06 -1.08 0.02 -2.27
Quarter Ending Jun-15 -1.03 -1.08 0.05 -4.65
Quarter Ending Mar-15 -1.68 -1.68 0.00 -0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.03 0.03 0.02 0.03 0.03
Quarter Ending Dec-16 0.03 0.03 0.02 0.03 0.03
Year Ending Dec-16 0.11 0.11 0.10 0.08 0.13
Year Ending Dec-17 0.13 0.13 0.10 0.09 0.03
Earnings (per share)
Quarter Ending Sep-16 -0.66 -0.66 -0.64 -0.77 -1.00
Quarter Ending Dec-16 -0.68 -0.68 -0.65 -0.79 -0.96
Year Ending Dec-16 -3.04 -3.04 -2.88 -3.26 -3.56
Year Ending Dec-17 -1.62 -1.62 -1.68 -1.68 -2.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.